What Is Driving the Pancreatic Cancer Therapy Market Growth?
Pancreatic cancer is among the most aggressive and lethal malignancies, with late-stage diagnosis common and survival rates historically low. This clinical reality has made it one of oncology's most urgent unmet needs—and one of its most active areas of therapeutic development. The market for pancreatic cancer therapies is expanding steadily, driven by rising disease incidence, a wave of...
0 Σχόλια 0 Μοιράστηκε 150 Views 0 Προεπισκόπηση